Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence P Carter

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Drug Testing and Analysis|October 1, 2011
Potential impact of drug effects, availability, pharmacokinetics, and screening on estimates of drugs implicated in cases of assaultLawrence P Carter
Drug and Alcohol Dependence|May 16, 2009
Principles of laboratory assessment of drug abuse liability and implications for clinical developmentLawrence P Carter, Roland R Griffiths
Medical Hypotheses|June 21, 2011
Possible role for glutamic acid decarboxylase in fibromyalgia symptoms: a conceptual model for chronic painCaris T Fitzgerald, Lawrence P Carter
Postgraduate Medicine|June 12, 2014
Patients' journeys to a narcolepsy diagnosis: a physician survey and retrospective chart reviewLawrence P Carter, Christine Acebo, Ann Kim
The European Journal of Neuroscience|November 15, 2006
Lack of effects of GHB precursors GBL and 1,4-BD following i.c.v. administration in ratsLawrence P Carter, Wouter Koek, Charles P France
Pharmacology & Therapeutics|November 18, 2008
Behavioral analyses of GHB: receptor mechanismsLawrence P Carter, Wouter Koek, Charles P France
Psychopharmacology|June 23, 2009
Cognitive, psychomotor, and subjective effects of sodium oxybate and triazolam in healthy volunteersLawrence P Carter, Roland R Griffiths, Miriam Z Mintzer
Drug and Alcohol Dependence|June 5, 2009
Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuseLawrence P Carter, Daniel Pardi, Jane Gorsline, et al.
Sleep Medicine|November 5, 2016
Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexyJed Black, Todd Swick, Richard Bogan, et al.
Clinical Pharmacology in Drug Development|September 16, 2020
A Randomized, Double-Blind, Placebo- and Positive-Controlled, 4-Period Crossover Study of the Effects of Solriamfetol on QTcF Intervals in Healthy ParticipantsKatie Zomorodi, Dan Chen, Lawrence Lee, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Drug Testing and Analysis|October 1, 2011
Potential impact of drug effects, availability, pharmacokinetics, and screening on estimates of drugs implicated in cases of assaultLawrence P Carter
Drug and Alcohol Dependence|May 16, 2009
Principles of laboratory assessment of drug abuse liability and implications for clinical developmentLawrence P Carter, Roland R Griffiths
Medical Hypotheses|June 21, 2011
Possible role for glutamic acid decarboxylase in fibromyalgia symptoms: a conceptual model for chronic painCaris T Fitzgerald, Lawrence P Carter
Postgraduate Medicine|June 12, 2014
Patients' journeys to a narcolepsy diagnosis: a physician survey and retrospective chart reviewLawrence P Carter, Christine Acebo, Ann Kim
The European Journal of Neuroscience|November 15, 2006
Lack of effects of GHB precursors GBL and 1,4-BD following i.c.v. administration in ratsLawrence P Carter, Wouter Koek, Charles P France
Pharmacology & Therapeutics|November 18, 2008
Behavioral analyses of GHB: receptor mechanismsLawrence P Carter, Wouter Koek, Charles P France
Psychopharmacology|June 23, 2009
Cognitive, psychomotor, and subjective effects of sodium oxybate and triazolam in healthy volunteersLawrence P Carter, Roland R Griffiths, Miriam Z Mintzer
Drug and Alcohol Dependence|June 5, 2009
Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuseLawrence P Carter, Daniel Pardi, Jane Gorsline, et al.
Sleep Medicine|November 5, 2016
Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexyJed Black, Todd Swick, Richard Bogan, et al.
Clinical Pharmacology in Drug Development|September 16, 2020
A Randomized, Double-Blind, Placebo- and Positive-Controlled, 4-Period Crossover Study of the Effects of Solriamfetol on QTcF Intervals in Healthy ParticipantsKatie Zomorodi, Dan Chen, Lawrence Lee, et al.
Pageof 5